Company Search:
Advanced Search
Sponsored Links
Bionomics Limited Company Snapshot
Bionomics Limited operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Bionomics Limited with three other companies in this sector in Australia: Pharmaxis Ltd (2017 sales of 17.64 million Australian Dollars [US$13.51 million] of which 77% was Bronchitol and Aridol), Tempo Australia Limited (18.51 million Australian Dollars [US$14.17 million] ), and Clinuvel Pharmaceuticals Limited (17.03 million Australian Dollars [US$13.04 million] of which 100% was Biotechnology).

Sales Analysis. During the year ended June of 2017, sales at Bionomics Limited were A$18.61 million (US$14.25 million). This is an increase of 128.5% versus 2016, when the company's sales were A$8.14 million. Sales of Drug Discovery and Development saw an increase of 199.4% in 2017, from A$5.48 million to A$16.42 million. Not all segments of Bionomics Limited experienced an increase in sales in 2017: sales of Contract Services fell 13.3% to A$5.75 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Bionomics Limited
  Stock Performance Chart for Bionomics Limited
  Stock Data: Recent Stock Performance:
  Current Price (4/20/2018): .62
(Figures in Australian Dollars)
1 Week 4.2%   13 Weeks 7.8%  
4 Weeks 65.3%   52 Weeks 75.9%  
Bionomics Limited Key Data:
  Ticker: BNO Country: Australia
  Exchanges: OTC Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2017 Sales 18,606,356
(Year Ending Jan 2018).
Employees: 140
  Currency: Australian Dollars Market Cap: 299,074,943
  Fiscal Yr Ends: June Shares Outstanding: 482,378,941
  Share Type: Ordinary Closely Held Shares: 54,909,334
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.